Travere Therapeutics
Price & Volume
Stats
See more52W Range | $12.91-$36.87 |
Market Cap | $3.2B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $435.8M |
Revenue Growth (YoY) | 162.1% |
Gross Profit (12 Mos) | $215.2M |
Diluted EPS | -$1.03 |
News
See moreYahoo Finance • 2 days ago
Why IBD 50's No. 2 Stock, Travere Therapeutics, Has Doubled In 2025
Yahoo Finance • 2 days ago
Why IBD 50's No. 3 Stock, Travere Therapeutics, Has Doubled In 2025
Yahoo Finance • 10 days ago
Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally
Yahoo Finance • 28 days ago
Travere signals readiness for rapid FILSPARI launch in FSGS as Q3 2025 revenue hits $164.9M
About
CEO | Dr. Eric M. Dube Ph.D. |
Address | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 385 |
